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a  b  s  t  r  a  c  t
Background:  Benzodiazepines  (BZs)  are  among  the  most  frequently  prescribed  drugs  with  the  potential  for
abuse. Young  adults  ages  18–29  report  the highest  rates  of BZ  misuse  in the  United  States.  The majority
of  club  drug  users  are  also  in  this  age  group,  and  BZ  misuse  is  prevalent  in  the  nightclub  scene.  BZ
dependence,  however,  is not  well  documented.  This  paper  examines  BZ  dependence  and  its correlates
among  multidrug  users  in  South  Florida’s  nightclub  scene.
Methods:  Data  were  drawn  from  structured  interviews  with  men  and  women  (N  =  521)  who  reported
regular  attendance  at large  dance  clubs  and  recent  use  of  both  club  drugs  and  BZs.
Results:  Prevalences  of  BZ-related  problems  were  7.9%  for BZ  dependence,  22.6%  BZ abuse,  and  25%  BZ
abuse  and/or  dependence.  In  bivariate  logistic  regression  models,  heavy  cocaine  use (OR  2.27;  95%  CI
1.18,  4.38),  severe  mental  distress  (OR  2.63;  95%  CI 1.33,  5.21),  and  childhood  victimization  history  (OR
2.43;  95%  CI 1.10,  5.38)  were  associated  with  BZ  dependence.  Heavy  cocaine  use  (OR  2.14;  95%  CI 1.10,
4.18)  and  severe  mental  distress  (OR 2.16;  95% CI 1.07,  4.37)  survived  as  predictors  in  the  multivariate
model.
Discussion:  BZ misuse  is widespread  among  multidrug  users  in the  club  scene,  who  also  exhibit  high  levels
of other  health  and  social  problems.  BZ  dependence  appears  to  be  more  prevalent  in  this  sample  than  in
other  populations  described  in  the  literature.  Recommendations  for intervention  and  additional  research
are described.
© 2011 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
1.1. Prescription medication misuse
The misuse of prescription drugs has become a considerable
public health problem over the past decade (Compton and Volkow,
2006). Although the vast majority of patients use them responsibly,
more than 15 million people report misusing prescription drugs for
a variety of reasons (Manchikanti, 2007), including to get high, to
get energy or to get to sleep, to moderate the effects of other drugs,
and to have fun (United States Food and Drug Administration,
2001; Kelly and Parsons, 2007). Recent estimates show that the
lifetime prevalence of prescription drug misuse trails only alco-
hol and marijuana (McCabe, 2005; Manchikanti, 2007); moreover,
emergency department visits for prescription drug misuse have
increased markedly in recent years, especially those involving
benzodiazepines, opioids, and central nervous system stimulants
(McCarthy, 2007; Substance Abuse and Mental Health Services
Administration, 2003). Perceptions of low risk associated with pre-
scription drug misuse may  contribute to the observed increases in
use; a survey conducted by the Partnership for a Drug Free America
∗ Corresponding author. Tel.: +1 305 529 1911; fax: +1 305 529 2501.
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(2006) found that 31% of respondents believed there was  nothing
wrong with taking medications without a prescription. The authors’
prior research also documented prevalent perceptions of prescrip-
tion drugs as both safer and purer than street drugs (Kurtz, 2004;
Inciardi et al., 2009).
1.2. Benzodiazepine misuse
Benzodiazepines (BZs) are among the most frequently pre-
scribed drugs with potential for abuse, yet these have not received
the same attention from regulatory agencies and researchers as
have opioid analgesics (Blakeslee, 2004). BZs are frequently pre-
scribed for short-term use to patients suffering from anxiety, acute
stress attacks, and sleep disorders (National Institute on Drug
Abuse, 2005), as well as more serious mental illnesses, such as
schizophrenia and bipolar disorder (Brunette et al., 2003). Com-
bining these medications with other substances such as alcohol or
opioids can diminish brain function and respiration to the point of
death (O’Brien, 2005; Bohnert et al., 2010). The non-medical use of
BZs continues to increase across a range of populations (Substance
Abuse and Mental Health Services Administration, 2003) because of
greater availability, more prescriptions being written, media adver-
tising, and lax monitoring of BZ use (National Institute on Drug
Abuse, 2002).
0376-8716/$ – see front matter ©  2011 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.drugalcdep.2011.05.036
100 S.P. Kurtz et al. / Drug and Alcohol Dependence 119 (2011) 99– 105
Although BZ misuse is widespread in the United States and
internationally (Haydon et al., 2005), certain populations, including
young adults (McCabe, 2005), may  be more likely to develop prob-
lematic use. Young adults ages 18–29 report the highest prevalence
of BZ misuse in the United States (Substance Abuse and Mental
Health Service Administration, 2008a,b), and the prevalence of BZ
misuse within club-going samples, most frequently young adults,
approaches 65–75% lifetime (Kelly and Parsons, 2007; Kurtz et al.,
2005; Grov et al., 2009). In a study of ecstasy-using nightclub atten-
dees, Kurtz (2004) found that a minority initiated BZ use in junior
high or high school coincident with initiation into alcohol or mari-
juana use, but that most began to misuse BZs at older ages for the
purpose of easing withdrawal from stimulants, such as ecstasy and
cocaine.
1.3. Benzodiazepine polydrug abuse
Polydrug users ingest multiple psychoactive substances within
a limited timeframe in order to increase or moderate the intensity
of the effects of other drugs; for example, consuming cocaine with
alcohol to prevent intoxication drowsiness (Compton and Volkow,
2006), or taking a sedative after ecstasy to fall asleep (Allott and
Redman, 2006). Other studies have found that BZ misusers are often
polydrug users (Harrell and Broman, 2009; McCabe, 2005), and
research with club scene participants indicates that BZs are often
included in drug combinations intended to increase the intensity of
intoxication (Hansen et al., 2001; Inciardi et al., 2007). Club atten-
dees also report using BZs with other drugs to mimic  the effects of
another drug they could not obtain, combining BZs with alcohol to
save money on drinks, and using BZs to come down from stimulants
(Kurtz, 2004).
Concerns about BZ polydrug use are particularly acute in South
Florida, where recent reports documented that 90% of fatalities
in which BZs were identified as the cause of death also involved
at least one other drug (Hall, 2009). In the same year, BZ misuse
accounted for 11% of emergency department reports involving drug
ingestion, and was among the five most commonly mentioned sub-
stances in this regard (cocaine, marijuana, MDMA,  and prescription
opioids and BZs).
1.4. Benzodiazepine dependence
BZ dependence can occur even when doses are low and con-
sumed over a short period of time (Fang et al., 2009; Lader et al.,
1984). Specific characteristics of BZs are believed to contribute
to their addictive potential (Fialip et al., 1987). Alprazolam and
lorazepam, for example, have a short half life, making users more
prone to seizures and intense withdrawal symptoms (Wolf and
Griffiths, 1991). Recent data from the National Survey on Drug
Use and Health (NSDUH) indicate that 2.3% of respondents misuse
sedatives and tranquilizers, and that 9.8% of these meet DSM-
IV criteria for abuse or dependence (Becker et al., 2007). Other
research has found rates of abuse and dependence to be somewhat
higher, affecting .6% and .5% of the United States population, respec-
tively (Sheehan and Raj, 2009; Substance Abuse and Mental Health
Service Administration, 2008a,b).
Although the surge in prescription drug misuse over the past
decade has been accompanied by increased research in this area,
concerns over BZ abuse and dependence are frequently overshad-
owed by regulatory and research initiatives targeting opioids. Given
the pharmacologic properties and abuse potential of BZs, their
widespread misuse represents a serious public health concern. This
paper describes BZ misuse among adults in South Florida’s night-
club scene and examines factors that predict BZ dependence.
2. Methods
2.1. Sampling plan and client recruitment
Data were drawn from a natural history study of 600 partic-
ipants in Miami’s club scene who use club drugs and also use
prescription medications for non-medical reasons (i.e., “we are only
interested in the times you used prescription medications other
than as prescribed by a doctor, for instance, to get high, for fun, to
relax or to come down”). The major goals of the project were to
examine the onset and progression of club and prescription drug
use, and to assess changes in health and social consequences of
this drug use over time. Participants were interviewed at base-
line and at three successive 6-month intervals. Data reported here
are from baseline interviews of the 521 participants who  reported
recent (past 90 days) use of BZs for non-medical reasons (hereafter,
misuse).
Eligible participants were 18–49 years old, willing to provide
contact information, and reported: (a) using one or more club drugs
at least three times during the past 90 days; (b) misusing one or
more psychoactive prescription medications (stimulants, opioids,
BZs, other sedatives, antipsychotics, and antidepressants) three
times or more in the past 90 days; and (c) regularly attending large
recognized nightclubs at least twice per month. Club drugs were
defined to include powder cocaine, ecstasy, GHB, ketamine and LSD.
Participants were recruited into the study between May
2006 and June 2008 through respondent-driven sampling (RDS;
Heckathorn, 1997). This method was  chosen so as to achieve a
broadly representative sample of men  and women in the club scene,
while also recognizing the difficulties, including intoxication, noise,
and heavy security, associated with recruiting drug users at club-
bing venues. Initial respondents (“seeds”), chosen for their diversity
in terms of gender, ethnicity, and age, were recruited through out-
reach and existing contacts in the club culture. Each seed and
subsequent study participant was  provided with five recruitment
coupons to give to other club drug users in their social network,
with the understanding that they would earn $50 for the recruit-
ment of each additional eligible respondent. Although this amount
may  seem large compared to other studies, the relatively high costs
associated with the clubbing lifestyle rendered the target popula-
tion unresponsive to lower levels of compensation for their time.
The coupons provided the recipients with information about the
study and a telephone number to call for eligibility screening. The
five coupon limit was intended to prevent a few recruiters with
large social networks from biasing the overall sample toward those
with similar demographic and drug using profiles (homophily)
and in order to lengthen the recruitment chains (Heckathorn,
1997). Theoretically, respondent-driven sampling has been shown
to quickly reduce sources of respondent bias (e.g., ethnicity, gen-
der) as successive waves of respondent contacts are enrolled and
then solicited for additional contacts (Heckathorn, 1997, 2002).
Although participants were not recruited at nightclubs, the clubs
they reported patronizing most often were large dance clubs that
are focused on the electronic music scene.
2.2. Field operations
The project was  housed in a field office strategically located
to facilitate access to a diverse population of club drug users. At
intake, the nature of the project was  explained by the research
staff, including its voluntary and confidential nature and the mon-
etary stipends. Each client was  screened for eligibility, followed
by informed consent and data collection. All interviews were
conducted in private offices using computer-assisted face-to-face
interviews. Clients received HIV and drug education literature,
condoms, and a $50 stipend upon completion of these baseline
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activities. Baseline screening and interviewing procedures lasted
2–3 h. Human subjects protocols were approved by the University
of Delaware’s Institutional Review Board.
2.3. Measures
The Global Appraisal of Individual Needs (GAIN; Dennis et al.,
2002) has eight core sections (demographics, substance use, phys-
ical health, risk behaviors, mental health, environment, legal
involvement and vocational attainment), with each containing
questions on the recency of problems, breadth of symptoms, and
recent prevalence in days or times. The items are combined into
scales and subscales that can be used for DSM IVR-based diagnoses
for substance use and mental health problems. Psychometric stud-
ies have found Cronbach’s alphas between .9 and .8; all have alphas
over .7, and test–retest correlations of .7–.8. We  adapted the GAIN
by expanding the prescription drug categories to include a wide
range of psychoactive prescription medications; past year abuse
and dependence symptoms were assessed for each drug. For ques-
tions about prescription drug use, participants were asked to only
report on non-medical use, as defined earlier.
Childhood victimization was assessed by an affirmative
response to any of the following events before the age of 18: being
attacked with a weapon; being beaten so as to cause bruises, cuts
or broken bones; being forced to participate in sexual acts against
one’s will; or being abused emotionally so as to cause very bad
feelings about oneself or one’s life.
The General Mental Distress Scale (GMDS) is comprised of past
year DSM-IV symptoms counts for depression (9 items), anxiety (12
items), and somatic disorders (4 items). This scale is reducible to
classifications indicating clinical significance (subclinical, moder-
ate and severe; Dennis et al., 2002) and was further dichotomized
in the analyses presented here into “severe” and “not severe.” Alpha
reliability coefficients for the depression, anxiety, and somaticism
subscales in this study were 0.863, 0.872, and 0.738, respectively.
Frequencies of use (days using out of the past 90 days) for
the most prevalent non-BZ substances other than marijuana (alco-
hol, powder cocaine and ecstasy) were dichotomized at the 75th
percentile, with use above that mark defined as “heavy.” Heavy
marijuana use was defined as every day use, which was reported
by 35.3% of the sample. A measure of BZ abuse, defined as the
endorsement of at least one of four DSM-IV criteria, was  included
for comparison to other studies. Seven DSM-IV dependence criteria
for BZs were reduced to “BZ dependent” (3 or more symptoms) and
“BZ non-dependent” (0–2 symptoms).
2.4. Data analyses
All analyses were conducted using the Predictive Analytics
Software (PASW formerly SPSS) version 18. Descriptive statistics
were calculated for the variables of interest, including gender,
race/ethnicity, age, living situation, education, substance use (for
the most commonly reported non-BZ substances), childhood vic-
timization, mental distress, and BZ DSM-IV abuse and dependence
symptoms. Descriptive information was also compiled on partic-
ipants’ age of onset for BZ misuse and the extent of lifetime and
recent BZ misuse.
Bivariate logistic regression models examined relationships
between demographic, non-BZ substance use, mental health, vic-
timization, and environmental factors and BZ dependence. Those
measures that exhibited significant predictive values in the bivari-
ate models were included in a multivariate logistic regression
model. The “other race/ethnicity” category, though significant in
the bivariate model, was not included in the multivariate model
because of the very small number of participants (N = 18) report-
ing this racial/ethnic identification. Hosmer and Lemeshow tests
confirmed that the predictors were a “good fit” for each model
(Tabachnick and Fidell, 2007).
3. Results
3.1. Sample characteristics
The sample for this report includes 521 participants (86.8% of
the 600 in the study) who  reported at least one occasion of mis-
use of alprazolam, diazepam, clonazepam or lorazepam in the
past 90 days. The most widely used BZ in the past 90 days was
alprazolam (N = 498); fewer participants reported using diazepam
(N = 83), clonazepam (N = 44), and lorazepam (N = 13). Forty-one
(7.9%) recent BZ misusers met  DSM-IV dependence criteria for
BZs. Demographic, substance use, mental health, victimization and
environmental characteristics of BZ dependent and non-dependent
misusers are shown in Table 1. [Summary results of chi-square and
t-tests of significance are also noted in Table 1 for information;
detailed statistical results of bivariate logistic regression analyses
are presented in Table 3].
A relatively young (mean age = 25.6; SD = 7.79) and educated
(mean = 12.3 years; SD = 2.07) sample of multidrug users was
recruited. The racial/ethnic makeup of the sample is broadly repre-
sentative of the overall population of Miami-Dade County, and also
reflects the remarkable ethnic diversity of the club scene. As to this
latter point, the three most popular nightclubs frequented by all
participants at study intake were the top three clubs for every eth-
nic and age group as well (data not shown). Symptoms indicating
severe levels of mental distress were reported by 46.8% of respon-
dents. Almost two-thirds (64.3%) said that they were physically,
emotionally and/or sexually abused before age 18.
3.2. Substance use
Participants reported using alcohol on an average of 45.5 days
(SD = 26.53), marijuana 60.5 days (SD = 33.70), powder cocaine 29.6
days (SD = 27.64) and ecstasy 14.1 (SD = 17.30) days in the past
3 months. These were the most prevalent non-BZ substances, as
98.3% of participants used alcohol, 94.8% marijuana, 90% cocaine,
and 84.1% ecstasy. Other current drug use (data not shown) was
also reported, including LSD by 19.8% of the sample, psiloscybin
(12.9%), crack cocaine (13.6%), methamphetamine (8.6%), heroin
(8.3%), and misuse of prescription opioids (55.3%). More than
two-thirds (70.7%) of BZ-dependent participants, and 18.5% of non-
BZ-dependent respondents, met  DSM-IV criteria for BZ abuse.
Summary results of tests for significant differences by BZ depen-
dence are also shown in Table 1. No demographic or environmental
differences between BZ dependent and BZ non-dependent partici-
pants were noted, except that those reporting “other race” reported
higher levels of dependence. Heavy cocaine use was associated with
BZ dependence, while heavy use of alcohol, marijuana or ecstasy did
not show such an association. Severe mental distress and childhood
victimization were also associated with BZ dependence.
Frequency and quantity of BZ misuse were strongly associated
with BZ dependence; BZ dependent participants reported using
BZs on more than twice as many days lifetime and in the past 3
months, and used nearly three times as many pills per month, as
non-BZ dependent misusers. BZ dependent misusers reported their
first misuse at an average age of 18, compared to age 20 for non-
dependent misusers, but this difference did not reach significance.
3.3. Benzodiazepine dependence
Table 2 shows the percentage of BZ dependent misusers who
endorsed each BZ-specific abuse or dependence criterion. The most
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Table  1
Sample characteristics by past year benzodiazepine dependence (N = 521).
Variable Non-dependent misusers Dependent misusers
N (480) % N (41) %
Age (mean; SD) 25.5 (7.7) 26.8 (9.3)
Gender
Male 287 59.8 21 51.2
Female 193 40.2 20 48.8
Race
White non-Hispanic 91 19.0 12 29.3
African-American 115 24.0 6 14.6
Hispanic 260 54.1 19 46.3
Other 14 2.9 4 9.8*
Education
High school diploma/GED or lessa 316 65.8 26 65.0
Some  college 164 34.2 14 35.0
Health and social characteristics
Live with parents 211 44.0 20 48.8
Severe mental distress (GMDS scale) 216 45.0 28 68.3**
Victimized before age 18 302 62.9 33 80.5*
Heavy substance use
Alcoholb 120 25.0 12 29.3
Marijuanac 171 35.6 13 31.7
Cocained 114 23.8 17 41.5*
Ecstasye 117 24.4 14 34.1
DSM-IV BZ abuse 89 18.5 29 70.7***
Benzodiazepine misuse (Mean; SD) (Mean; SD)
Age at first misuse 20 (06.8) 18 (05.7)
Days misuse lifetime 424 (757.2) 1116 (1230.0)###
Days misuse past 90 days 23 (24.4) 49 (31.1)###
Pills misused per typical month 15 (23.4) 39 (42.3)###
a One missing case.
b 4th quartile = 66 or more days use.
c Every day = 90 days use.
d 4th quartile = 46 or more days use.
e 4th quartile = 21 or more days use.
* 2 = p ≤ .05.
** 2 = p ≤ .01.
*** 2 = p ≤ .001.
### t = p ≤ .001.
commonly endorsed abuse criteria were failing to meet responsi-
bilities and using BZs in unsafe situations. Social problems caused
by BZ misuse were reported by less than 30% of dependent mis-
users, and legal problems were rare. A large majority (80.5%) of
dependent misusers reported spending a lot of time getting, using,
and feeling the effects of BZs. Needing more drug to get the same
high and continuing use despite recognition that BZs caused medi-
cal, emotional or psychological problems were endorsed by almost
two-thirds of dependent misusers. The remaining four depen-
dence criteria were endorsed by about one-half of dependent
misusers.
Results of the bivariate logistic regression models predicting
BZ dependence are shown in Table 3. Demographic characteris-
tics, including gender, age, race/ethnicity, and education, were not
associated with BZ dependence. In terms of substance use, only
past 90 days heavy cocaine use was associated with BZ depen-
dence; odds of BZ dependence were two times higher among heavy
users compared to those using cocaine less frequently. Odds of BZ
dependence for participants scoring in the severe clinical range
on mental distress were 2.6 times higher than for those reporting
lower levels of mental distress; participants who reported child-
hood abuse had 2.4 times higher odds of meeting BZ dependence
criteria than those who had not been victimized before the age of
18.
Finally, the significant bivariate predictors of BZ dependence
were included in a multivariate logistic regression model (see
Table 4). The three bivariate predictors – heavy cocaine use, severe
mental distress and childhood victimization – were each associated
with approximately two  times higher odds of BZ dependence in the
multivariate model, although the childhood victimization measure
failed to reach statistical significance.
Table 2
Abuse and dependence criteria endorsed by BZ dependent participants (N = 41).
N % of BZ
dependent
Abuse criteria
Kept using BZ, despite causing failure to meet
responsibilities
24 58.5
Used BZ in unsafe or dangerous situations 17 41.5
Kept using BZ, despite causing social problems
(e.g., fights)
12 29.3
BZ  use caused repeated problems with the law 3 7.3
Dependence criteria
Spent a lot of time getting, using or feeling the
effects of BZ
33 80.5
Needed more BZ to get the same high 27 65.9
Kept using BZ despite causing medical,
emotional, psych problems
26 63.4
Unable to cut down or stop using BZ 23 56.1
BZ  use caused you to give up or problems at
work, home or school
23 56.1
Used BZ in larger amounts or more often than
intended
20 48.8
Had BZ withdrawal problems (e.g., shaking,
trouble sleeping)
19 46.3
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Table 3
Bivariate logistic regression models of predictors of BZ dependence (N = 521).
Predictor of BZ dependence p OR 95% CI
Demographic characteristics
Female .286 1.416 0.748, 2.683
White non-Hispanic .116 1.769 0.869, 3.599
Age .312 1.020 0.982, 1.060
Education > high schoola .915 1.038 0.527, 2.041
Health and social characteristics
Live with parents .757 0.903 0.473, 1.725
Severe mental distress (GMDS scale) .005 2.632 1.331, 5.206
Victimized before age 18 .028 2.431 1.099, 5.380
Heavy substance use
Alcoholb .547 1.241 0.614, 2.509
Marijuanac .615 0.839 0.423, 1.662
Cocained .014 2.274 1.180, 4.382
Ecstasye .169 1.609 0.816, 3.170
a One missing case.
b 4th quartile = 66 or more days use.
c Every day = 90 days use.
d 4th quartile = 46 or more days use.
e 4th quartile = 21 or more days use.
4. Discussion
4.1. Benzodiazepine misuse and dependence
Consistent with past research (Becker et al., 2007), alprazolam
and diazepam were the most widely misused BZs in our sample,
with 95.6% and 15.9% of BZ misusers reporting past 90 days use
for each, respectively. Reports of prevalence of BZ dependence (as
opposed to abuse and/or dependence) among BZ misusers are not
apparent in the literature. One study of patients with co-occurring
mental health and substance use disorders found that 15% of pre-
scribed BZ users and 6% of non-prescribed users met  DSM-IV BZ
abuse and/or dependence criteria (Brunette et al., 2003). Becker
et al. (2007) found a 9.8% sedative/tranquilizer abuse/dependence
rate in a large national sample of sedative/tranquilizer misusers.
The prevalence of BZ-related abuse and dependence problems
among our sample of club scene participants would appear to be
much higher, with 7.9% meeting dependence criteria, 22.6% abuse
criteria, and 25.0% abuse and/or dependence.
Several explanations may  account for these higher levels of
reported BZ-related problems among men  and women in the club
scene compared to the other available reports. The sample for this
study regularly used a wide variety of substances with the explicit
goal of getting high in a dance club context, or coming down from
stimulants they used there. It is possible that the interaction of
various substances increased the levels of problems participants
attributed to BZs, or that our sample misused larger quantities
and/or dosage sizes than respondents in other reported studies.
Although data are not available to answer these questions, BZ abuse
and dependence problems may  well be concentrated in certain high
risk populations. Compared to substance abuse treatment clients,
club drug users are a somewhat hidden population, and their levels
of BZ-related problems are serious concerns.
The DSM-IV symptom most commonly endorsed by BZ depen-
dent misusers was failing to meet responsibilities, indicating that
their use was negatively impacting important aspects of their lives.
Table 4
Multivariate logistic regression model of predictors of BZ dependence (N = 521).
Predictor of BZ dependence p OR 95% CI
Severe mental distress (GMDS scale) .031 2.163 1.072, 4.366
Heavy cocaine usea .025 2.144 1.100, 4.178
Victimized before age 18 .082 2.063 0.912, 4.665
a 4th quartile = 46 or more days use.
Many misusers who  met  dependence criteria also reported using
in unsafe situations, which resonates with the established link
between BZ use and traffic accidents (Bramness et al., 2002). The
least endorsed abuse criterion for dependent BZ misusers was  hav-
ing repeated problems with the law. This suggests that BZ misusers
may  not behave in ways consistent with drug-related arrests, or
alternatively, that if participants did experience problems with
the law, they did not attribute the problem to their BZ use. Kurtz
(2004) found that club-goers were generally unconcerned about
legal sanctions related to possession of prescription drugs, and felt
they would be able to adequately explain such possession even in
the absence of a prescription.
Each of seven DSM-IV dependence criteria was endorsed by
about one-half or more of BZ-dependent participants. The large
majority (65.9%) reported needing increased amounts of the medi-
cation to get high, indicating that tolerance was  a significant issue.
Almost as many (63.4%) reported continuing to misuse BZs despite
physical emotional or psychological problems. Although the pro-
portion experiencing withdrawal symptoms was somewhat lower
at 45%, these data are consistent with the plethora of literature
indicating severe withdrawal symptoms based on the pharmacoki-
netics of BZs, and specifically alprazolam (Wolf and Griffiths, 1991;
Vorma et al., 2003).
Heavy cocaine use was significantly associated with BZ depen-
dence in this sample. This finding is not surprising given the level
of multidrug use within club scene (Inciardi et al., 2007) and BZ
using (McCabe, 2005; Compton and Volkow, 2006) populations. BZs
have been reported by club drug users to be used for both increas-
ing intoxication levels and coming down from other drugs (Kurtz,
2004). Given the complexity of these multidrug and polydrug use
behaviors and the different physical and psychological manifes-
tations of dependence on different drugs, additional research is
needed to examine how BZ dependence coincides and interacts
with other substance dependence disorders.
Finally, both severe mental distress and childhood victimization
were strongly associated with BZ dependence, although only severe
mental distress remained as a significant predictor in the multi-
variate model. The levels of serious mental distress and childhood
victimization reported by the sample were higher than anticipated,
as these characterizations of urban club scene participants are not
apparent in the literature. Given the lack of additional data to con-
textualize these findings, it seems likely that the study drug use
eligibility requirements resulted in an especially high risk sam-
ple. Young adults with extensive victimization histories might be
especially attracted to the escapism of the club scene, and to suf-
fer greater drug-involvement through their participation in it, than
their non-victimized peers. Further, childhood victimization has
been linked with a range of psychosocial problems in adulthood
relevant to this sample, including severe mental distress and sub-
stance use (Meade et al., 2009).
The link between mental distress and BZ dependence is likely
complex, although consistent with prior research showing that
people with psychiatric disorders experience high rates of BZ mis-
use and dependence (Kidorf et al., 1996; Martınez-Cano et al., 1999;
Brunette et al., 2003). Persons experiencing severe mental distress
may  use BZs to self medicate (Chutuape and de Wit, 1995) and
subsequently become dependent on the medication. Alternatively,
mental distress may  result from BZ misuse and dependence, as past
research has shown that depressive symptoms tend to decline as
BZ use declines (Schreiber et al., 2008).
4.2. Limitations
Although the RDS recruitment procedures resulted in a sample
of participants broadly representative of the racial/ethnic makeup
of the County, our ability to generalize the findings to the popula-
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tion of club goers in Miami  may  be limited by the study eligibility
requirements requiring regular, recent use of club drugs and misuse
of prescription medications. As well, the assessments of mental dis-
tress symptoms were conducted by trained research interviewers
rather than by clinical professionals; as such, caution is warranted
when comparing the prevalence of psychological distress in our
study with those utilizing clinician-administered interviews.
4.3. Conclusion
The prevalence and consequences of BZ misuse among our sam-
ple serve to reemphasize the importance of strengthened measures
to stem the diversion of psychoactive medications into illicit mar-
kets. Demand reduction measures are also needed for BZ misusers
who acquire their medications without the benefit of labels describ-
ing appropriate uses and warnings. Knowledge of the risks of BZ
misuse is likely low among men  and women in the club scene,
and these risks are exacerbated by their use of BZs in sequence
or combination with a wide range of other substances.
Developing intervention approaches specific to this population
is a complex undertaking, however, because drug use is considered
to be fashionable, not problematic, in the club scene. Moreover,
these young men  and women tend to be suspicious of and disinter-
ested in anything health authorities say about the risks associated
with substance use (Marsden et al., 2006; Whittingham et al., 2009).
Given this, peer-based approaches would likely meet with greater
success, including, perhaps, web- and venue-based informational
campaigns that do not rely on academic, governmental or other
expert-delivered messages.
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